International Clinical Trial: A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of UCB0159 in Participants With Mild to Moderate Psoriasis, Single Dose Pharmacokinetics and Safety in Healthy Participants

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07849894) titled 'A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of UCB0159 in Participants With Mild to Moderate Psoriasis, Single Dose Pharmacokinetics and Safety in Healthy Participants' on Sept. 24.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: UCB Biopharma SRL

Condition: Mild to Moderate Psoriasis Healthy Volunteers

Intervention: Drug: UCB0159

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrol...